Insider · CIK 0001208853
Margaret Dalesandro
Files at SEEL (SEELOS THERAPEUTICS, INC.), SKYE (Skye Bioscience, Inc.), AMAM (Ambrx Biopharma, Inc.). First filing -, latest -.
In brief
Margaret Dalesandro files SEC Form 4 as director at SEEL (SEELOS THERAPEUTICS, INC.), and also at SKYE (Skye Bioscience, Inc.), AMAM (Ambrx Biopharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Margaret Dalesandro has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | AMAM Ambrx Biopharma, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -17,857 | - | - | 0 | Mar 7, 2024 |
| Mar 7, 2024 | AMAM Ambrx Biopharma, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -10,119 | - | - | 0 | Mar 7, 2024 |
| Feb 29, 2024 | SKYE Skye Bioscience, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Mar 4, 2024 |
| Jan 4, 2024 | SEEL SEELOS THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +1,666 | $0.00 | $0 | 1,666 | Jan 8, 2024 |
| Nov 6, 2023 | SKYE Skye Bioscience, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +14,110 | $0.00 | $0 | 20,001 | Nov 6, 2023 |
Questions about Margaret Dalesandro
Answered from the filings on this page, as of the latest one.
Is Margaret Dalesandro buying or selling?
Margaret Dalesandro has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Margaret Dalesandro's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Margaret Dalesandro has 0.
Where does Margaret Dalesandro file Form 4?
Margaret Dalesandro has filed Form 4 at SEEL (SEELOS THERAPEUTICS, INC.); SKYE (Skye Bioscience, Inc.); AMAM (Ambrx Biopharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.